GlassScriptPhysician profile
Ashley Noelle Davis
NPI 1689800955
$15,179.49
in general payments reported to CMS, 2019-2025
40 companies · $1,817 in 2025
The $1,817 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,311 · 2020: $247 · 2021: $1,023 · 2022: $1,352 · 2023: $4,792 · 2024: $637 · 2025: $1,817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,186 · Food and Beverage: $2,011 · Consulting Fee: $1,550 · Education: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,185.66 |
| Food and Beverage | $2,010.64 |
| Consulting Fee | $1,550.00 |
| Education | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,649.25 | 2019-2025 | |
| Gynesonics, INC. | $3,275.93 | 2021-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Medical Device Business Services, INC. | $1,182.83 | 2022-2023 | |
| Abbvie INC. | $930.86 | 2019-2023 | Orilissa |
| Hologic Sales and Service, LLC | $623.73 | 2019-2025 | Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Myovant Sciences INC. | $521.52 | 2021-2022 | |
| Asensus Surgical, INC. | $406.54 | 2019 | |
| Meditrina | $371.95 | 2020-2023 | |
| Sumitomo Pharma America, INC. | $257.69 | 2023-2025 | Myfembree |
| Lupin INC. | $163.41 | 2019-2020 | |
| Exeltis, USA INC. | $151.12 | 2019-2022 | |
| Thd America, INC. | $136.65 | 2020-2023 | |
| Conmed Corporation | $125.91 | 2023-2024 | Conmed Generators |
| Pfizer INC. | $121.19 | 2021-2024 | |
| Daiichi Sankyo INC. | $118.08 | 2020-2023 | Injectafer |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.